{
  "trial_id": "NCT02956837",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Subjects who, in the opinion of the investigator, can and will comply with the requirements of the protocol.",
      "label": "met"
    },
    {
      "criterion": "Written informed consent obtained from the subject prior to performance of any study specific procedure.",
      "label": "met"
    },
    {
      "criterion": "Non-pregnant female between, and including, 18 and 45 years of age at the time of study vaccination.",
      "label": "not_met"
    },
    {
      "criterion": "Healthy subjects as established by medical history and clinical examination before entering into the study.",
      "label": "met"
    },
    {
      "criterion": "Female subjects of non-childbearing potential may be enrolled in the study",
      "label": "unknown"
    },
    {
      "criterion": "Non-childbearing potential is defined as pre-menarche, hysterectomy, ovariectomy or post-menopause.",
      "label": "met"
    },
    {
      "criterion": "Female subjects of childbearing potential may be enrolled in the study, if the subject: Has practiced adequate contraception for 30 days prior to study vaccination, and Has a negative pregnancy test on the day of study vaccination, and Has agreed to continue adequate contraception up to 90 days after vaccination.",
      "label": "unknown"
    },
    {
      "criterion": "She is menopausal",
      "label": "met"
    },
    {
      "criterion": "She has no underlying disease",
      "label": "met"
    },
    {
      "criterion": "It is her first vaccination this year.",
      "label": "unknown"
    },
    {
      "criterion": "She works at a rehab center",
      "label": "unknown"
    },
    {
      "criterion": "She takes daily multivitamins and anti-hypertensive drugs",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Use of any investigational or non-registered product other than the study vaccines within 30 days prior to study vaccination, or planned use during the study period.",
      "label": "unknown"
    },
    {
      "criterion": "Chronic administration of immunosuppressants or other immune-modifying drugs, as well as administration of long-acting immune-modifying drugs, within 6 months prior to study vaccination, or planned administration until 90 days post-vaccination.",
      "label": "not_met"
    },
    {
      "criterion": "Administration of immunoglobulins and/or any blood products during the period starting 3 months before the study vaccination, or planned administration until 90 days post-vaccination.",
      "label": "unknown"
    },
    {
      "criterion": "Planned administration/administration of a vaccine not foreseen by the study protocol within the period starting 30 days before and ending 30 days after study vaccination, with the exception of any licensed influenza vaccine which may be administered \u2265 15 days before or after study vaccination.",
      "label": "unknown"
    },
    {
      "criterion": "Previous experimental vaccination against RSV.",
      "label": "not_met"
    },
    {
      "criterion": "History of any neurological disorders or seizures.",
      "label": "not_met"
    },
    {
      "criterion": "Family history of congenital or hereditary immunodeficiency.",
      "label": "unknown"
    },
    {
      "criterion": "Any confirmed or suspected immunosuppressive or immunodeficient condition, based on medical history and physical examination",
      "label": "not_met"
    }
  ],
  "notes": "The patient is a healthy woman with no underlying disease. She has been menopausal for some time and has no allergies to any food or drugs.",
  "_meta": {
    "topic_id": "69",
    "trial_id": "NCT02956837",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}